Open AccessFour-year follow-up of a patient with mixed cardiomyopathy and an implanted cardiac contractility modulation device: a case report
Author(s) -
Т. М. Ускач,
А. А. Сафиуллина,
Ю. Ш. Шарапова,
V.A. Amanatova,
А. А. Петрухина,
М. И. Макеев,
С Н Терещенко
Publication year - 2021
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2021-2811
Subject(s) - medicine , contractility , heart failure , cardiology , ejection fraction , cardiotoxicity , cardiomyopathy , dilated cardiomyopathy , chemotherapy
The article presents a case report of a 28-year-old male patient with mixed dilated cardiomyopathy: myocardial noncompaction and chemotherapy-related cardiotoxicity, which led to severe heart failure (HF). With optimal drug therapy, the patient was implanted with a cardiac contractility modulation device in order to improve exercise tolerance, quality of life and relieve HF symptoms. Complex therapy has led to significant clinical and echocardiographic improvement. This case demonstrates a 4-year follow-up of a patient with a reduced left ventricular ejection fraction and an implanted cardiac contractility modulation device, whose condition, after several severe HF decompensations, was stabilized.